Birchview Capital’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$380K Sell
98,882
-31
-0% -$127 0.22% 58
2025
Q4
$367K Buy
98,913
+20,329
+26% +$174K 0.21% 56
2025
Q3
$1.11M Buy
78,584
+44,000
+127% +$686K 0.84% 33
2025
Q2
$664K Buy
34,584
+10,000
+41% +$156K 0.66% 33
2025
Q1
$272K Hold
24,584
0.24% 48
2024
Q4
$409K Buy
24,584
+23,917
+3,586% +$299K 0.33% 38
2024
Q3
$6.77K Hold
667
0.01% 60
2024
Q2
$38.5K Buy
+667
New +$32.7K 0.04% 59

Other funds holding OM

Birchview Capital's OM Position: Q1 2026 in Review

Birchview Capital reduced its Outset Medical (OM) stake by 0.03% in Q1 2026, selling an estimated $127 and leaving 98,882 shares worth $380K. The position accounts for 0.22% of the portfolio, ranked #58.

Birchview Capital first reported a position in OM in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.11M in Q3 2025. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Birchview Capital held 98,882 shares of Outset Medical worth $380K as of Q1 2026.
  • Birchview Capital sold 31 Outset Medical shares in Q1 2026, an estimated $127.
  • Outset Medical made up 0.22% of Birchview Capital's portfolio in Q1 2026, its #58 holding.
  • Birchview Capital first reported a position in Outset Medical in Q2 2024 and has held it in 8 quarters since.
  • Birchview Capital's Outset Medical position peaked at $1.11M in Q3 2025.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Birchview Capital's 13F filing for Q1 2026, filed 15 May 2026.